BioPharmSignal logoBioPharmSignal

Biotech News

Veradigm Files 2023 and 2024 Form 10-K

Veradigm (MDRX)Veradigm2026-06-25 13:46 ESTSEC filing

Reaches Major SEC Filing Milestone; Now Advancing 2025 and 2026 Filings CHICAGO --(BUSINESS WIRE)--May 26, 2026-- Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on

Open original release

Related news

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Extends Stockholder Rights Plan

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Provides Business and Strategy Update

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

View all latest news

Veradigm

Veradigm is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MDRXVeradigm2026-06-26 11:23 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-06-26 11:23 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-26 11:23 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-26 11:23 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-26 11:23 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States